Larry L Wood

President, CEO

Larry L Wood (President, CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Edwards Lifesciences Corporation (EW). Across 1 priced purchase filing, the average 21-session return was +13.6% from execution and +0.8% from disclosure (delay-adjusted; derived). The largest single filing was $498K of PRCT (23,900 sh × $20.85, as filed), executed Aug 7.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+13.6%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+0.8%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$498K

shares × price, as filed

Last traded

Aug 7

Filed Aug 10

Median ADV $427.2M across their filed names

Open performance→

Volume by month

Buys $498K Sells $3.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

Edwards Lifesciences Corporation EW · 0 buys · 3 sells 3 filings PRCT PROCEPT BioRobotics Corporation PRCT · 1 buy · 0 sells 1 filing

Recent filings

PRCTPURCHASE PROCEPT BioRobotics Corporation View filing → $498K
23,900 sh × $20.85
Exec Aug 7
Filed Aug 10 · 6:07 AM ET EWSALE Edwards Lifesciences Corporation View filing → $699K
8,950 sh × $78.06
Exec Aug 18 2025
Filed Aug 18 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation View filing → $673K
8,950 sh × $75.23
Exec Jun 16 2025
Filed Jun 16 2025 · 5:30 PM ET EWSALE Edwards Lifesciences Corporation View filing → $1.6M
25,000 sh × $65.91
Exec Nov 5 2024
Filed Nov 5 2024 · 5:30 PM ET